Literature DB >> 18453496

Risk factors for drug resistant tuberculosis in southeast Turkey.

A Cetin Tanrikulu1, Salih Hosoglu, Tuncer Ozekinci, Abdurrahman Abakay, Fuat Gurkan.   

Abstract

We undertook a cross-sectional survey of 116 patients at Dicle Hospital, Turkey, who had with bacteriologically confirmed tuberculosis (TB). Demographic and clinical features, including age, gender, pulmonary TB history, associated diabetes mellitus, previous TB treatment, residential area and education, were collected from charts. Eighty-four of the strains were found to be susceptible to all drugs. The resistance to one or more drug(s) was found in 32 strains. Multi-drug resistant (MDR) TB was found in 13 strains (11.3% of the total and 40.7% of the drug resistant strains). The resistance to isoniazid was the most frequently seen (25 strains, 21.5%). In the multivariable analysis, only previous TB treatment (P = 0.000) remained a significant predictor for drug resistance; in MDR, previous TB treatments (P = 0.002) remained significant in the final model. The patient's educational status was found to be negatively correlated with the risk of MRD-TB (P = 0.035). Previous TB treatment and low educational status were found to important risk factors for the development of MDR-TB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18453496     DOI: 10.1258/td.2007.070131

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  17 in total

Review 1.  Tuberculosis and diabetes mellitus: convergence of two epidemics.

Authors:  Kelly E Dooley; Richard E Chaisson
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

2.  Clinical characteristics, drug resistance, and treatment outcomes among tuberculosis patients with diabetes in Peru.

Authors:  M J Magee; E Bloss; S S Shin; C Contreras; H Arbanil Huaman; J Calderon Ticona; J Bayona; C Bonilla; M Yagui; O Jave; J P Cegielski
Journal:  Int J Infect Dis       Date:  2013-02-22       Impact factor: 3.623

3.  Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis.

Authors:  Ying Xi; Wei Zhang; Rui-Jun Qiao; Jun Tang
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

4.  Spatial epidemiology and spatial ecology study of worldwide drug-resistant tuberculosis.

Authors:  Yunxia Liu; Shiwen Jiang; Yanxun Liu; Rui Wang; Xiao Li; Zhongshang Yuan; Lixia Wang; Fuzhong Xue
Journal:  Int J Health Geogr       Date:  2011-08-03       Impact factor: 3.918

5.  Association between Multidrug-Resistant Tuberculosis and Risk Factors in China: Applying Partial Least Squares Path Modeling.

Authors:  Yun-Xia Liu; Chun-Kun Pang; Yanxun Liu; Xiu-Bin Sun; Xin-Xu Li; Shi-Wen Jiang; Fuzhong Xue
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

6.  Drug-resistant tuberculosis in Mumbai, India: An agenda for operations research.

Authors:  Nerges Mistry; Monica Tolani; David Osrin
Journal:  Oper Res Health Care       Date:  2012-06

7.  Risk factors and drug-resistance patterns among pulmonary tuberculosis patients in northern Karnataka region, India.

Authors:  Gajanan S Gaude; Jyothi Hattiholli; Praveen Kumar
Journal:  Niger Med J       Date:  2014-07

Review 8.  Diabetes-related tuberculosis in the Middle East: an urgent need for regional research.

Authors:  Yosra M Alkabab; Hail M Al-Abdely; Scott K Heysell
Journal:  Int J Infect Dis       Date:  2015-09-25       Impact factor: 3.623

9.  Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.

Authors:  Xiaoliang Yuan; Tiantuo Zhang; Kazuyoshi Kawakami; Jiaxin Zhu; Wenzheng Zheng; Hongtao Li; Guofang Deng; Shaohua Tu; Weiyou Liu
Journal:  BMC Infect Dis       Date:  2013-07-12       Impact factor: 3.090

10.  Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia.

Authors:  Matthew J Magee; Russell R Kempker; Maia Kipiani; Nestani Tukvadze; Penelope P Howards; K M Venkat Narayan; Henry M Blumberg
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.